Prognosis of unresectable
pancreatic cancer is poor with the rate of surviving more than 5 years is less than 10% despite multi-modalities
treatment. The American Society of
Clinical Oncology suggested that all
patients with metastatic
pancreatic cancer should be offered information about clinical trials. Endoscopic ultrasound guided
radio frequency ablation has been recently used in
patients with advanced stage
pancreatic cancer in a few studies. This article has reviewed information from published articles using endoscopic ultrasound guided
radio frequency ablation for advanced
pancreatic cancer.